DelveInsight’s “Spinal Cord Injury (SCI) Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the Spinal Cord Injury (SCI), historical and forecasted epidemiology as well as the Spinal Cord Injury (SCI) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Spinal Cord Injury (SCI) market report provides current treatment practices, emerging drugs, Spinal Cord Injury (SCI) market share of the individual therapies, current and forecasted Spinal Cord Injury (SCI) market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Spinal Cord Injury (SCI) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the Spinal Cord Injury (SCI) market.
Some of the key facts of the Spinal Cord Injury Market:
- Among the European five countries, Germany had 80,850 cases which is the highest, followed by Italy in 2021. On the other hand, Spain had the lowest number of diagnosed cases.
- Among the cause-specific i.e., Vehicular incidents were found to be a major cause of SCI followed by Falls.
Got queries? Click here to know more about the Spinal Cord Injury Market Landscape
Spinal Cord Injury Overview
Spinal cord injury (SCI) is a serious medical condition that causes functional, psychological, and socioeconomic disorders. Long-term, secondary medical complications are common and play an important role in the continuum of care for patients with SCI. Complications are a frequent cause of morbidity and mortality and lead to increased rates of re-hospitalization, loss of employability, and decreased quality of life. The most common cause of spinal cord injury is trauma. Nearly half of the injuries are caused by motor vehicle accidents. Other types of trauma include: falls from height, violence (stabbing or gunshot wounds to the spine), and sporting injuries (diving, football, rugby, equestrian, etc.).
A spinal cord injury is a traumatic event that results in disturbances to normal sensory, motor, or autonomic function and ultimately affects a patient’s physical, psychological, and social well-being. Acute SCI consists of a primary phase and a secondary phase. The initial traumatic impact on the spinal cord, in the form of fracture or dislocation, causes microhemorrhages in the white and grey matter, axonal damage, and cellular membrane destruction. Following the primary injury, a cascade of pathophysiological events results in impaired neuronal homeostasis, apoptosis, and tissue destruction.
Spinal Cord Injury Epidemiological Insight:
- The incidence of SCI in the rest of the world is much lower than in the United States. There are several possible explanations for this. One is the relative absence in most countries of SCI because of acts of violence. However, there also appear to be fewer SCIs related to motor vehicle crashes in other countries.
- The total diagnosed cases of SCI in the 7MM was estimated to be 722,217 cases in 2021, which is expected to increase in the forecast period (2022-2032)
- Among the 7MM countries, the United States had the highest number of diagnosed cases of SCI followed by Japan, Germany, and Italy in 2021. On the other hand, Spain had the lowest number of diagnosed cases.
- Total type-specific cases of SCI in the US was assessed to be 323,296, which is expected to increase in the forecast period
Spinal Cord Injury Epidemiological Segmentation
- Total cases of Spinal Cord Injury
- Total diagnosed cases of Spinal Cord Injury
- Total Gender specific cases of Spinal Cord Injury
- Total Cause-specific cases of Spinal Cord Injury
- Total neurological level cases of Spinal Cord Injury
Spinal Cord Injury Market Outlook
The Spinal Cord Injury (SCI) market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Spinal Cord Injury (SCI) market trends by analyzing the impact of current Spinal Cord Injury (SCI) therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Spinal Cord Injury (SCI) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Spinal Cord Injury (SCI) market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Spinal Cord Injury (SCI) market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @ Spinal Cord Injury Market Trends
Spinal Cord Injury Key Companies
- Elezanumab
- Lineage Cell Therapeutics
- Abbvie
- And many more
Spinal Cord Injury Key Therapies
- Elezanumab (ABT-555)
- AST-OPC1
- Elezanumab
- And many more
Table of Contents
- Key Insights
- Report Introduction
- Executive Summary of Spinal Cord Injury Market
- Disease Background and Overview
- Epidemiology and patient population
- The United States
- EU 5
- Spinal Cord Injury Market Emerging Therapies
- Spinal Cord Injury Market Outlook
- Market Access and Reimbursement of Therapies
- Appendix
- Spinal Cord Injury Market Report Methodology
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Click here to read more about Spinal Cord Injury Market Insights
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Adya Kaul
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/